Literature DB >> 23986580

Preservation of dendritic cell function during vesicular stomatitis virus infection reflects both intrinsic and acquired mechanisms of resistance to suppression of host gene expression by viral M protein.

Marlena M Westcott1, Maryam Ahmed, Jason R Smedberg, Karishma R Rajani, Elizabeth M Hiltbold, Douglas S Lyles.   

Abstract

Inhibition of host-directed gene expression by the matrix (M) protein of vesicular stomatitis virus (VSV) effectively blocks host antiviral responses, promotes virus replication, and disables the host cell. However, dendritic cells (DC) have the capacity to resist these effects and remain functional during VSV infection. Here, the mechanisms of DC resistance to M protein and their subsequent maturation were addressed. Flt3L-derived murine bone marrow dendritic cells (FDC), which phenotypically resemble resident splenic DC, continued to synthesize cellular proteins and matured during single-cycle (high-multiplicity) and multicycle (low-multiplicity) infection with VSV. Granulocyte-macrophage colony-stimulating factor (GM-CSF)-derived myeloid DC (GDC), which are susceptible to M protein effects, were nevertheless capable of maturing, but the response was delayed and occurred only during multicycle infection. FDC resistance was manifested early and was type I interferon (IFN) receptor (IFNAR) and MyD88 independent, but sustained resistance required IFNAR. MyD88-dependent signaling contributed to FDC maturation during single-cycle infection but was dispensable during multicycle infection. Similar to FDC, splenic DC were capable of maturing in vivo during the first 24 h of infection with VSV, and neither Toll-like receptor 7 (TLR7) nor MyD88 was required. We conclude that FDC resistance to M protein is controlled by an intrinsic, MyD88-independent mechanism that operates early in infection and is augmented later in infection by type I IFN. In contrast, while GDC are not intrinsically resistant, they can acquire resistance during multicycle infection. In vivo, splenic DC resist the inhibitory effects of VSV, and as in multicycle FDC infection, MyD88-independent signaling events control their maturation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23986580      PMCID: PMC3807369          DOI: 10.1128/JVI.00680-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Induction of optimal anti-viral neutralizing B cell responses by dendritic cells requires transport and release of virus particles in secondary lymphoid organs.

Authors:  B Ludewig; K J Maloy; C López-Macías; B Odermatt; H Hengartner; R M Zinkernagel
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

2.  Marginal zone macrophages and immune responses against viruses.

Authors:  Stephan Oehen; Bernhard Odermatt; Urs Karrer; Hans Hengartner; Rolf Zinkernagel; Constantino López-Macías
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

Review 3.  Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens.

Authors:  William R Heath; Gabrielle T Belz; Georg M N Behrens; Christopher M Smith; Simon P Forehan; Ian A Parish; Gayle M Davey; Nicholas S Wilson; Francis R Carbone; Jose A Villadangos
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

Review 4.  Type I interferons in host defense.

Authors:  Daniel B Stetson; Ruslan Medzhitov
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

Review 5.  Interplay between innate immunity and negative-strand RNA viruses: towards a rational model.

Authors:  Denis Gerlier; Douglas S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2011-09       Impact factor: 11.056

Review 6.  The restriction factors of human immunodeficiency virus.

Authors:  Reuben S Harris; Judd F Hultquist; David T Evans
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

7.  Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures.

Authors:  Shalin H Naik; Anna I Proietto; Nicholas S Wilson; Aleksandar Dakic; Petra Schnorrer; Martina Fuchsberger; Mireille H Lahoud; Meredith O'Keeffe; Qi-xiang Shao; Wei-feng Chen; José A Villadangos; Ken Shortman; Li Wu
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

Review 8.  Antiviral antibody responses: the two extremes of a wide spectrum.

Authors:  Lars Hangartner; Rolf M Zinkernagel; Hans Hengartner
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

9.  Matrix protein mutant of vesicular stomatitis virus stimulates maturation of myeloid dendritic cells.

Authors:  Maryam Ahmed; Kristina L Brzoza; Elizabeth M Hiltbold
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

10.  Interferon response and viral evasion by members of the family rhabdoviridae.

Authors:  Elizabeth J Faul; Douglas S Lyles; Matthias J Schnell
Journal:  Viruses       Date:  2009-11-09       Impact factor: 5.048

View more
  4 in total

1.  Signaling pathways in murine dendritic cells that regulate the response to vesicular stomatitis virus vectors that express flagellin.

Authors:  Jason R Smedberg; Marlena M Westcott; Maryam Ahmed; Douglas S Lyles
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

2.  Sensing of immature particles produced by dengue virus infected cells induces an antiviral response by plasmacytoid dendritic cells.

Authors:  Elodie Décembre; Sonia Assil; Marine L B Hillaire; Wanwisa Dejnirattisai; Juthathip Mongkolsapaya; Gavin R Screaton; Andrew D Davidson; Marlène Dreux
Journal:  PLoS Pathog       Date:  2014-10-23       Impact factor: 6.823

3.  Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin.

Authors:  Marlena M Westcott; Jason Smedberg; Matthew J Jorgensen; Shelby Puckett; Douglas S Lyles
Journal:  Vaccines (Basel)       Date:  2018-03-19

4.  Investigating Functional Roles for Positive Feedback and Cellular Heterogeneity in the Type I Interferon Response to Viral Infection.

Authors:  Sivan Leviyang; Igor Griva
Journal:  Viruses       Date:  2018-09-21       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.